Patients with multiple sclerosis (MS) who receive interferon (IFN)- -1a [`Avonex']

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.355, 2002-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patients with multiple sclerosis (MS) who receive interferon (IFN)- -1a [`Avonex']

By  

Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Interferon--1b: Glioma in patients with multiple sclerosis: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1108, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 1, 2017-01 ,pp. : 93-101

Bentham Science Publishers

Access to resources Recommend Favorite

Interferon-Beta Therapy Monitoring in Multiple Sclerosis Patients

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 1, 2009-03 ,pp. : 14-28

Bentham Science Publishers

Access to resources Recommend Favorite

Interferon-β1b for the treatment of multiple sclerosis

By Lam Sum   Wang Shan   Gottesman Malcolm  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite